|
|
||||||||
|
FIGURE 1. PSDI and EVR24 of all 167 patients with systemic amyloidosis (AA, AL, and ATTR types). Patients are subdivided according to intensity of scintigraphic uptake, represented by x (negative, n = 28),
(score 1+, n = 45),
(score 2+, n = 32), and (score 3+, n = 62). Dotted lines are reference limits of controls (>0.51 for PSDI and <50% for EVR24), resulting in reference area in upper left quadrant.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |